Autoimmunity News

Thursday, July 23, 2009 New Anti-TNF Adverse Effect: Sarcoid-like Granuloma
Sarcoid-like granulomas are a newly identified adverse effect associated with all types of TNF-blockade...

Tuesday, July 21, 2009 Belimumab Meets Lupus Phase 3 Endpoint
Benlysta^® (belimumab, formerly LymphoStat-B) was significantly better that standard care in the phase 3 BLISS-52 trial...

Thursday, July 16, 2009 Hand BMD Predicts RA Mortality
Hand bone mineral density measured by digital X-ray radiogrammetry may help doctors better predict risk of joint damage and mortality among individuals with RA...

Tuesday, July 07, 2009 Quercetin Boosts Exercise Capacity
New research shows that quercetin supplementation boosts endurance and maximal oxygen capacity in healthy, active but untrained men and women...

Wednesday, July 01, 2009 Masitinib Pilot Study Shows Promise in DMARD-resistant RA
The first drug to target mast cells in RA shows promising early results in an uncontrolled phase 2a trial...

Tuesday, June 23, 2009 MMF Effective, Safe for Proliferative as well as Membranous Lupus Nephritis
Mycophenolate mofetil (CellCept) may be as effective as, yet safer than, cyclophosphamide for the proliferative lupus glomerulonephritis...

Tuesday, May 26, 2009 Little Science Behind Most Alternative Raynaud’s Remedies
Many patients with Raynaud's phenomenon try alternatives to conventional care, but a new analysis finds little data to support use of most such approaches...

Thursday, May 14, 2009 FDA OKs UCB's Cimzia for Moderate to Severe RA
Cimzia^® (certolizumab pegol), the only pegylated anti-TNF, has been approved for use in the US...

Tuesday, April 28, 2009 RA Patients Could Be Hard Hit By Swine Flu
Rheumatologists must be vigilant in looking for signs and symptoms of the swine flu in their immunocompromised patients—including those on TNF-inhibitors...

Monday, April 27, 2009 Two Big Steps for Lupus Nephritis Research
Genes that encode CXCR4/CXCL12 and kallikrein help determine whether lupus patients will develop kidney damage...